Zepp Health Corporation Sponsored ADR (NYSE:ZEPP - Get Free Report) shares reached a new 52-week high on Tuesday . The company traded as high as $49.96 and last traded at $46.49, with a volume of 326699 shares. The stock had previously closed at $45.00.
Analyst Ratings Changes
A number of research firms have weighed in on ZEPP. Fundamental Research set a $60.23 target price on Zepp Health and gave the stock a "buy" rating in a research report on Tuesday, August 26th. Wall Street Zen upgraded Zepp Health to a "hold" rating in a research report on Saturday, August 16th. One investment analyst has rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock currently has an average rating of "Buy" and a consensus price target of $60.23.
View Our Latest Report on ZEPP
Zepp Health Price Performance
The business has a 50-day moving average price of $19.40 and a 200 day moving average price of $8.54. The company has a current ratio of 1.10, a quick ratio of 0.78 and a debt-to-equity ratio of 0.31. The company has a market cap of $643.95 million, a price-to-earnings ratio of -9.39 and a beta of 1.31.
Zepp Health Company Profile
(
Get Free Report)
Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Zepp Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zepp Health wasn't on the list.
While Zepp Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.